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Volume substitution in case of circulatory insta-
bility is widely practiced, and it is regarded as a
cornerstone in treatment of for example hypov-
olemia and septic shock. Recently, the type of
fluid used in volume substitution has attained a
widespread interest. Large prospective random-
ized controlled trials have been performed, com-
paring different fluids in resuscitation. The
results have been debated extensively. Guideli-
nes are produced, but the issue remains contro-
versial. In clinical practice in Europe and in
Scandinavia, there is a large variability in indi-
cations for fluid therapy, in the choice of fluid
used, and also in how to monitor the effect and
the result.1
In this perspective, the recent publishing of
Scandinavian clinical practice guideline on
choice of fluid in resuscitation of critically ill
patients with acute circulatory failure by a
working group within the Scandinavian Society
of Anesthesiology and Intensive Care Medicine
is helpful.2 The authors used the Grading of
Recommendations Assessment, Development
and Evaluation (GRADE) methodology after
having systematically searched the literature for
recently updated systematic reviews of random-
ized clinical trials (RCTs) comparing crystalloid
solutions with colloid solutions. They ask a
number of very relevant questions and come up
with three strong recommendations; to use crys-
talloids rather than hydroxyl ethyl starch for
resuscitation in general ICU patients and in sep-
sis, and to use crystalloids rather than any col-
loid for resuscitation in trauma. In the
summary, they conclude a recommendation to
use crystalloids rather than colloids for resusci-
tation in the majority if critically ill patients.
As pointed out by the authors the strength of
this guideline is the use of the GRADE method-
ology including a transparent process. The major
limitation, also pointed out by the authors, is
the lack of subgrouping of patients based on the
indication for fluid therapy. It is a big leap for-
ward to have access to guidelines produced by
authors familiar to the Scandinavian reality in
terms of traditions, epidemiology, clinical routi-
nes, and case-mix. Most important is perhaps
how the guideline exposes the shortage of evi-
dence on the level of randomized controlled
clinical trials for some situations.
The concern over the use of hydroxyl ethyl
starch containing colloid solutions is now well
documented and the authors find that this mer-
its for strong recommendations. There has been
(and still is) shortage of documentation for the
perioperative use of hydroxyl ethyl starch and
for the use in acute resuscitation. Still emerging
results from observational studies support the
concern raised. Also perioperative use appears
to be associated with an increased risk of acute
kidney injury.3
The remaining issues include whether or not
any colloid is a better choice than a crystalloid
solution perioperatively, in any critical illness
or in trauma. Although the Scandinavian Clini-
cal Practice Guidelines give a strong recommen-
dation for the use of crystalloids rather than
colloids, they characterize the level of evidence
as very low. The main problem is that random-
ized clinical trials in accordance with the Hel-
sinki Declaration include a consent from patient
or proxy to be randomized, and this means that
the period before inclusion is not protocolized.
Still there are a number of situations where the
informed consent may be waived by the Ethics
Committee in order to make it possible to gain
proper evidence also in this type of very acute
situations. Hopefully investigators may succeed
in performing the necessary studies to produce
guidelines with high level of evidence also for
emergency situations.
Management end points and monitoring of
fluid therapy in critically ill patients remain to
be a major problem in clinical practice. The tra-
ditional way of circulatory monitoring gives us
an incomplete picture of the circulatory status.4
Heart rate and blood pressure are clearly
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insufficient in many situations. Pulse rate gives
more information, as the character of the pulse
and the peripheral temperature may be esti-
mated when pulse rate is palpated, preferably at
different sites. Peripheral capillary refill and
general skin color and moisture of oral mucosa
may add further information. These observations
and measurements may be done by any health
care professional. More dynamic measures of
the cardiovascular system include; echocardiog-
raphy and ultrasound of larger vessels and there
are a variety of techniques to measure or esti-
mate stroke volume and cardiac output. How-
ever, these are not always applicable or even
necessary. Functional measures such as mental
status and urinary output should also be
included in a circulatory assessment as well as
basic blood tests such as hemoglobin concentra-
tion, base excess and lactate. Regardless of
choice of circulatory monitoring, an indication
for fluid administration needs to be specified, as
well as type and intensity of monitoring
required.
Concerning fluid management one should
keep in mind the study from East Africa, where
children with septic shock had a higher mortal-
ity rate after being given boluses of albumin.5
The external validity of that study in Scandi-
navia is of course limited, but the physiology
involved with that study remains to be
explained and understood. It is quite common
that an immediate effect upon blood pressure is
the sole argument to give boluses of albumin
also today in Scandinavia. The short term effect
is often, but not always, obvious. The long term
effect, however, is not well characterized.6
In conclusion, the Scandinavian clinical prac-
tice guideline on choice of fluid in resuscitation
of critically ill patients with acute circulatory
failure is a welcome and helpful initiative, and
it is important to implement it into clinical rou-
tines. At the same time, the limitations of the
randomized controlled clinical trials, which
build up the evidences behind the guidelines
and the knowledge gaps there are, must be rec-
ognized. In saying that it is also important to
realize that we should have an obligation to
help to bridge these gaps of knowledge by par-
ticipating in well designed studies that are pre-
sented to us.
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